Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase
Tishova Y.,
Kalinchenko S.,
Mskhalaya G.,
Hackett G.,
Livingston M.,
König C.,
Strange R.,
Zitzmann M.,
Mann A.,
Maarouf A.,
Ramachandran S.
Связанные документы (рекомендация CORE)